MAXCYTE INC Share Price Today: Live Updates & Key Insights

MAXCYTE INC share price today is $0.7805, up 1.69%. The stock opened at $0.7367 against the previous close of $0.7525, with an intraday high of $0.7741 and low of $0.7355.

MAXCYTE INC Share Price Chart

MAXCYTE INC

us-stock
To Invest in {{usstockname}}
us-stock

MAXCYTE INC Share Price Performance

$0.7805 0.0169(1.69%) MXCT at 23 Mar 2026 02:23 PM Medical Devices
Lowest Today 0.7355
Highest Today 0.7741
Today’s Open 0.7367
Prev. Close 0.7525
52 Week High 3.17
52 Week Low 0.64
Day’s Range: Low 0.7355 High 0.7741
52-Week Range: Low 0.64 High 3.17
1 day return -
1 Week return -7.04
1 month return +0.69
3 month return -53.72
6 month return -51.02
1 year return -75.98
3 year return -81.76
5 year return -95.52
10 year return -

MAXCYTE INC Institutional Holdings

BlackRock Inc 9.36

Mirabella Financial Services LLP 7.69

Morgan Stanley - Brokerage Accounts 6.28

Vanguard Group Inc 5.19

Vitruvian Partners 4.73

Cadian Capital Management LP 3.45

Mudita Advisors LLP 3.16

RGI UK Listed Smaller Coms B Acc 3.09

AXA Framlington Health Fund - R Income 2.60

BNP Paribas Asset Management (Former AXA IM) 2.60

Vanguard Total Stock Mkt Idx Inv 2.57

Geode Capital Management, LLC 2.36

iShares Russell 2000 ETF 2.34

Unicorn AIM VCT Ord 2.33

State Street Corp 2.13

Citadel Advisors Llc 1.40

Millennium Management LLC 1.21

Vanguard Institutional Extnd Mkt Idx Tr 1.09

Jacobs Levy Equity Management, Inc. 0.96

Fidelity Small Cap Index 0.94

Dimensional Fund Advisors, Inc. 0.91

iShares Russell 2000 Value ETF 0.82

Willis Investment Counsel 0.81

River UK Micro Cap Ord 0.78

Northern Trust Corp 0.74

Renaissance Technologies Corp 0.74

MI Chelverton UK Equity Growth B Acc 0.66

D. E. Shaw & Co LP 0.62

State St Russell Sm/Mid Cp® Indx SL Cl I 0.55

Fidelity Extended Market Index 0.53

Jane Street Group LLC 0.50

Vanguard Russell 2000 ETF 0.45

UBS Group AG 0.44

BlackRock Advantage Small Cap Core Instl 0.36

State St Russell Sm Cap® Indx SL Cl I 0.35

Morgan Stanley Inception 0.33

Morgan Stanley Inst Inception I 0.33

Vanguard Health Care ETF 0.29

MGTS AFH DA UK Equity I GBP Acc 0.25

Blackrock Extended Mkt Fund CF 0.25

MAXCYTE INC Market Status

Strong Buy: 6

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

MAXCYTE INC Fundamentals

Market Cap 81.63 M

PB Ratio 0.4528

PE Ratio 0.0

Enterprise Value -5.94 M

Total Assets 239.47 M

Volume 935259

MAXCYTE INC Company Financials

Annual Revenue FY23:38047000 38.0M, FY22:44261500 44.3M, FY21:33894100 33.9M, FY20:26168900 26.2M, FY19:21620700 21.6M

Annual Profit FY23:33331600 33.3M, FY22:39163100 39.2M, FY21:30246700 30.2M, FY20:23401900 23.4M, FY19:19121500 19.1M

Annual Net worth FY23:-37454600 -37.5M, FY22:-19781100 -19.8M, FY21:-20126600 -20.1M, FY20:-12642000 -12.6M, FY19:-13576100 -13.6M

Quarterly Revenue Q3/2025:6829000 6.8M, Q2/2025:8507000 8.5M, Q1/2025:10390000 10.4M, Q3/2024:8164000 8.2M, Q2/2024:10429000 10.4M

Quarterly Profit Q3/2025:6313000 6.3M, Q2/2025:6988000 7.0M, Q1/2025:8893000 8.9M, Q3/2024:6236000 6.2M, Q2/2024:7907000 7.9M

Quarterly Net worth Q3/2025:-12416000 -12.4M, Q2/2025:-12357000 -12.4M, Q1/2025:-10261000 -10.3M, Q3/2024:-11557000 -11.6M, Q2/2024:-9375000 -9.4M

About MAXCYTE INC & investment objective

Company Information MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Organisation Medical Devices

Employees 114

Industry Medical Devices

CEO Mr. Maher Masoud

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

MAXCYTE INC FAQs

What is the share price of MAXCYTE INC today?

The current share price of MAXCYTE INC is $0.7805.

Can I buy MAXCYTE INC shares in India?

Yes, Indian investors can buy MAXCYTE INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy MAXCYTE INC shares in India?

You can easily invest in MAXCYTE INC shares from India by:

Can I buy fractional shares of MAXCYTE INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of MAXCYTE INC?

MAXCYTE INC has a market cap of $81.63 M.

In which sector does MAXCYTE INC belong?

MAXCYTE INC operates in the Medical Devices sector.

What documents are required to invest in MAXCYTE INC stocks?

To invest, you typically need:

What is the PE and PB ratio of MAXCYTE INC?

The PE ratio of MAXCYTE INC is N/A and the PB ratio is 0.45.